Servier Worldwide

  • 1st independent French pharmaceutical company.
  • Over 20,000 employees.
  • Nearly 3000 researchers preparing the drugs of the future.
  • All profit is invested in Research and Development.
  • 44 new chemical entities currently under development in the following therapeutic fields: cardiovascular diseases, central nervous system and psychiatry, cancer research, diabetes and metabolism, and rheumatology.
  • Present in 140 countries over 5 continents. 92% of Servier’s medicines are prescribed internationally.
  • A turnover of 3.9 billion euros for 2012.